Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | S2812Vfs*3 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM S2812Vfs*3 indicates a shift in the reading frame starting at amino acid 2812 and terminating 3 residues downstream causing a premature truncation of the 3056 amino acid Atm protein (UniProt.org). S2812Vfs*3 has not been characterized, however, due to the effects of other truncation mutations downstream of S2812 (PMID: 16603769), is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM S2812Vfs*3 |
Transcript | NM_000051.4 |
gDNA | chr11:g.108345757dupG |
cDNA | c.8433dupG |
Protein | p.S2812Vfs*3 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005271562.5 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108345757dupG | c.8433dupG | p.S2812Vfs*3 | RefSeq | GRCh38/hg38 |
Molecular Profile | Protein Effect | Treatment Approaches |
---|---|---|
ATM S2812Vfs*3 | loss of function - predicted | Olaparib |